Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04181294 · ClinicalTrials.gov registry record · NA
Time Limited Trials to Reduce Non-Beneficial Intensive Care Unit Treatments
A NA study of Critical Illness and Communication, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 209
- Enrollment target
- 3
- Study locations
NCT04181294 is a NA study of Critical Illness and Communication that has completed, run by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. The registered enrollment target is 209 participants, below the 3,136-participant average among 91 other Critical Illness trials with a reported enrollment target (93% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT04181294, a NA study of Critical Illness and Communication, has completed, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 209 participants
- Enrollment target
- 3
- Study locations
Study Summary
Overutilization of intensive care unit (ICU) treatments among patients with advanced medical illnesses and poor prognosis places them at risk for prolonged suffering with minimal anticipated benefit. Improving communication and shared decision-making between providers and patients/family members represents an opportunity to reduce potentially non-beneficial treatments. Time limited trials (TLTs) are agreements between clinicians and patients/surrogate decision-makers to use medical therapies over a defined period of time to observe if patients improve or deteriorate according to agreed-upon clinical outcomes. The objective of this project is to examine whether a quality improvement intervention that uses protocoled time limited trials as the default ICU communication/care planning strategy for patients with advanced medical illnesses will decrease the duration and intensity of non-beneficial ICU treatments without changing hospital mortality.
Conditions Studied
Interventions
- BEHAVIORAL Family meetings using time limited trials as default ICU communication and care planning approach
- BEHAVIORAL Usual practice
Study Locations (3)
California
- Los Angeles County-University of Southern California Medical Center - Los Angeles
- Olive View Medical Center - Sylmar
- Harbor UCLA Medical Center - Torrance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04181294
The ClinicalTrials.gov registry entry for NCT04181294 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 209 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,136-participant average among 91 other Critical Illness trials with a reported enrollment target (93% lower). The listed sponsor is Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Critical Illness appearing as the primary indexed condition, and to 2 interventions - of which Family meetings using time limited trials as default ICU communication and care planning approach is the first listed.
NCT04181294 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04181294 about?
NCT04181294 is a clinical study titled "Time Limited Trials to Reduce Non-Beneficial Intensive Care Unit Treatments". Overutilization of intensive care unit (ICU) treatments among patients with advanced medical illnesses and poor prognosis places them at risk for prolonged suffering with minimal anticipated benefit. Improving communication and shared decision-making between providers and patients/family members rep...
What is the current status of trial NCT04181294?
This trial is currently completed. It is a NA study. The enrollment target is 209 participants. The study started on 2017-08-01. Estimated completion is 2019-12-31.
What conditions does trial NCT04181294 study?
This clinical trial studies the following conditions: Critical Illness, Communication.
What interventions are being tested in trial NCT04181294?
The interventions under investigation include: Family meetings using time limited trials as default ICU communication and care planning approach (BEHAVIORAL), Usual practice (BEHAVIORAL).
Who is sponsoring clinical trial NCT04181294?
This trial is sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04181294 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
RECRUITING · NA
-
Improving Needs Among Older Adults
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
12-hour Time Limited Feeding in Critical Care
RECRUITING · NA
-
PUSH-IT Continuing Enteral Feeds for Tracheostomy
RECRUITING · NA
-
Reestablishing Sleep and Circadian Alignment in Medical Intensive Care Unit (MICU) Patients Via a Mechanistic RCT of an Sleep Chronobundle
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.